Tens of thousands of tumour samples which have been stored in the basement of a London hospital for more than 70 years could be the key to unlocking the mystery of why bowel cancer cases are rising in ...

Thousands of men with prostate cancer in England will be offered a more precise form of radiotherapy that cuts treatment time by up to 75 per cent, based on the results of a trial led by The Institute ...

A targeted cancer treatment given via a simple injection under the skin shrank tumours in more than one third of patients with recurrent and/or metastatic head and neck cancer whose disease has ...

Results from the international Phase III RAMPART trial were presented today at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting by researchers from The Institute of Cancer Research ...

The Institute of Cancer Research (ICR) has welcomed the approval of ambitious new plans to create a home for oncology and life-sciences companies in Sutton, south London. The plans describe the ...

Being overweight or obese is an important cause of rising cancer rates among younger adults in England, according to a major new study. Researchers at The Institute of Cancer Research, London, and ...

Since the discovery of X-rays in 1895, radiation therapy, or radiotherapy, has made substantial advancements as a cancer treatment. It’s now responsible for approximately 40 per cent of cancer cures.

A team co-led by researchers at The Institute of Cancer Research, London, has uncovered how treatment-resistant cancer cells may drive poor outcomes for people with triple-negative breast cancer (TNBC ...

Scientists have created the most comprehensive map to date of the genetic mutations that fuel cancer – opening the door to extending precision treatments to thousands more patients and offering clues ...

We want to make sure our trials are inclusive and accessible to everyone affected by cancer, no matter their background, ethnic group or personal circumstances. When designing trials we work with ...

Scientists at The Institute of Cancer Research, London, are supporting an international clinical trial of a promising new immunotherapy treatment for advanced ovarian cancer. Biotechnology firm ...

A new drug for prostate cancer, which delivers a precisely targeted dose of radiation to cancer cells, can keep cancer at bay, a phase I trial reports. The ‘search and destroy’ treatment shrank ...